CD276 and neoplasm: The controlling of B7-H3 CAR-T cells to SUP-M2 cells was further monitored by tumor burden measurements (bioluminescence imaging, BLI, and tumor size), T cell persistence (hCD45+CD3+ cell counts in blood), body weight, and survival rate.